MAPK8 and cancer: Since the c-Jun activation domain is phosphorylated only by the JNKs, and the c-Jun promoter activity is autoregulated by c-Jun/AP-1, we treated the above 7 kinds of cancer cell lines with specific JNK inhibitor SP600125 to find out the most sensitive cancer cells to c-Jun.